Accelerate Diagnostics (AXDX) Announces Proposed Stock Offering

Go back to Accelerate Diagnostics (AXDX) Announces Proposed Stock Offering

Accelerate Diagnostics Announces Proposed Public Offering of Common Stock

August 17, 2022 6:00 PM UTC

TUCSON, Ariz., Aug. 17, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate Diagnostics") today announced that it has commenced an underwritten public offering of shares of its common stock. Accelerate Diagnostics expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering at the public offering price, less the underwriting discounts and commissions. Accelerate Diagnostics anticipates using the net proceeds from the offering for general corporate... More